DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Gastaldelli A, Repetto E, Guja C. et al.
Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes.
Diabetes Obes Metab 2020;
22 (03) 393-403
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.